These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
157 related items for PubMed ID: 6266066
1. Effects of any epoxymethano stable analogue of prostaglandin endoperoxides (U-46619) on human platelets. di Minno G, Bertelé V, Bianchi L, Barbieri B, Cerletti C, Dejana E, de Gaetano G, Silver MJ. Thromb Haemost; 1981 Apr 30; 45(2):103-6. PubMed ID: 6266066 [Abstract] [Full Text] [Related]
2. Effect of the polyamine-spermine on agonist-induced human platelet activation--specific inhibition of "aggregation-independent" events induced by thrombin, but not by collagen, thromboxane mimetic, phorbol ester or calcium ionophore. Joseph S, Krishnamurthi S, Kakkar VV. Thromb Haemost; 1987 Apr 07; 57(2):191-5. PubMed ID: 3110996 [Abstract] [Full Text] [Related]
3. Inhibitory effects of the selective thromboxane receptor antagonist BM 13.177 on platelet aggregation, vasoconstriction and sudden death. Patscheke H, Stegmeier K, Müller-Beckmann B, Sponer G, Staiger C, Neugebauer G. Biomed Biochim Acta; 1984 Apr 07; 43(8-9):S312-8. PubMed ID: 6097235 [Abstract] [Full Text] [Related]
4. Investigation on a selective non-prostanoic thromboxane antagonist, BM 13.177, in human platelets. Patscheke H, Stegmeier K. Thromb Res; 1984 Feb 01; 33(3):277-88. PubMed ID: 6424261 [Abstract] [Full Text] [Related]
5. Thromboxane A2 causes feedback amplification involving extensive thromboxane A2 formation on close contact of human platelets in media with a low concentration of ionized calcium. Packham MA, Kinlough-Rathbone RL, Mustard JF. Blood; 1987 Sep 01; 70(3):647-51. PubMed ID: 3620698 [Abstract] [Full Text] [Related]
6. Regulation of human platelet activation--analysis of cyclooxygenase and cyclic AMP-dependent pathways. Krishnamurthi S, Westwick J, Kakkar VV. Biochem Pharmacol; 1984 Oct 01; 33(19):3025-35. PubMed ID: 6091666 [Abstract] [Full Text] [Related]
7. Influence of trapidil derivatives on arachidonic acid- and prostaglandin endoperoxide analogue- induced platelet aggregation and thromboxane A2 formation. Heinroth I, Block HU, Mest HJ. Biomed Biochim Acta; 1984 Oct 01; 43(8-9):S389-92. PubMed ID: 6440555 [Abstract] [Full Text] [Related]
8. Platelet reactivity in vitro in relation to thromboxane in healthy pregnancy. Horn EH, Hardy E, Cooper J, Heptinstall S, Rubin PC. Thromb Haemost; 1996 Feb 01; 75(2):346-51. PubMed ID: 8815588 [Abstract] [Full Text] [Related]
9. Platelet activation induced by a stable analogue of endoperoxides (U46619). Zatta A, Prosdocimi M. Thromb Haemost; 1989 Apr 25; 61(2):328-9. PubMed ID: 2526389 [No Abstract] [Full Text] [Related]
10. Pretreatment of human platelets with plasmin inhibits responses to thrombin, but potentiates responses to low concentrations of aggregating agents, including the thrombin receptor activating peptide, SFLLRN. Kinlough-Rathbone RL, Perry DW, Rand ML, Packham MA. Thromb Haemost; 1997 Apr 25; 77(4):741-7. PubMed ID: 9134653 [Abstract] [Full Text] [Related]
11. Thromboxane synthase inhibitors suppress more effectively the aggregation of thromboxane receptor-desensitized than that of normal platelets: role of adenylylcyclase up-regulation. Vezza R, Nenci GG, Gresele P. J Pharmacol Exp Ther; 1995 Dec 25; 275(3):1497-505. PubMed ID: 8531121 [Abstract] [Full Text] [Related]
12. Increased binding of fibrinogen to platelets in diabetes: the role of prostaglandins and thromboxane. DiMinno G, Silver MJ, Cerbone AM, Riccardi G, Rivellese A, Mancini M, Thiagarajan P. Blood; 1985 Jan 25; 65(1):156-62. PubMed ID: 2981130 [Abstract] [Full Text] [Related]
13. Reactions of polylysine with human platelets in plasma and in suspensions of washed platelets. Guccione MA, Packham MA, Kinlough-Rathbone RL, Perry DW, Mustard JF. Thromb Haemost; 1976 Nov 30; 36(2):360-75. PubMed ID: 827032 [Abstract] [Full Text] [Related]
14. Augmentation of U46619 induced human platelet aggregation by aspirin. Kim JM, Koo YK, Jin J, Lee YY, Park S, Yun-Choi HS. Platelets; 2009 Mar 30; 20(2):111-9. PubMed ID: 19235053 [Abstract] [Full Text] [Related]
16. Effects of ticlopidine administered to healthy volunteers on platelet function in whole blood. Heptinstall S, May JA, Glenn JR, Sanderson HM, Dickinson JP, Wilcox RG. Thromb Haemost; 1995 Nov 30; 74(5):1310-5. PubMed ID: 8607115 [Abstract] [Full Text] [Related]
17. Platelet prostanoids in interaction of platelets with collagen substrates. II. Effects of exogenous arachidonic acid, stable PG endoperoxides analogue, and aspirin. Mazurov AV, Leytin VL, Repin VS, Taube C, Förster W. Biomed Biochim Acta; 1984 Nov 30; 43(8-9):S373-6. PubMed ID: 6440553 [Abstract] [Full Text] [Related]
18. The binding of [3H]9,11-dideoxy,9 alpha-11 alpha-methanoepoxy prostaglandin F2 alpha (U 46619) to washed human platelets. Jaschonek K, Faul C, Weisenberger H, Schmidt H, Renn W. Prog Clin Biol Res; 1989 Nov 30; 301():327-33. PubMed ID: 2529551 [No Abstract] [Full Text] [Related]
19. [Thrombocyte interaction with a collagen substrate: the role of thrombocyte-synthesized prostaglandin endoperoxides and thromboxane A2]. Mazurov AB, Leĭtin VL, Repin VS. Biull Eksp Biol Med; 1984 Nov 30; 98(11):563-6. PubMed ID: 6439262 [Abstract] [Full Text] [Related]
20. Licofelone, an inhibitor of cyclooxygenase and 5-lipoxygenase, specifically inhibits cyclooxygenase-1-dependent platelet activation. Rotondo S, Krauze-Brzósko K, Manarini S, Evangelista V, Cerletti C. Eur J Pharmacol; 2004 Mar 19; 488(1-3):79-83. PubMed ID: 15044038 [Abstract] [Full Text] [Related] Page: [Next] [New Search]